Along with the driving wheel medical demand growth and policy toencourage, more and more social capital came into the field of medical services,Over the years,"medical treatment is difficult, expensive medical treatment" hasbeen criticized, rooted in the lack of false high medical service market supplyand prices. With the Opportunity what drivingby " new medical reform", Thehealth care industry in China ushered in the development of newopportunities.Many pharmaceutical companies to expand into the medicalservices for the extension of industry chain. More and more investors begin topay close attention to the field of medical service.At the same time, we should pay attention to the development potential ofmedical service with huge field are attracting investors,On the other hand, themedical service industry has its own law of development and access barriers.Only fully understand and grasp the law of development of industry that canrealize the true value of the investment.The author thinks thatXinBangpharmaceutical rely on medical talents output and the capital expansion asacombination of investment is the key to the success of the investment.In this paper, through case study on XinBangpharmaceutical recombinantdepartment, First of all,introduces the reorganization of the assets section KeKaimedicine business situation. Analyzed theKeKaiassets as of hospital medicinecore assets. In the implementation of the restructuring, XinBang pharmaceuticalnot only is the future long-term development direction is clear, and absorb theasset quality of medicine have a strong support for the performance of the listingCorporation in thefuture to create short-term, XinBang pharmaceuticalpharmaceutical industry chain has a synergistic effect and significance. Throughthe analysis and valuation of the two companies comparative analysis of financialindicators and the reorganization of corporate restructuring for the company tofurther explain the overall value of the significance, and provides a goodreference value for investors to invest in the asset class... |